Logo image of GUG

GUGGENHEIM ACTIVE ALLOCATION (GUG) Stock Price, Quote, News and Overview

NYSE:GUG - New York Stock Exchange, Inc. - US40170T1060 - Currency: USD

15.59  +0.32 (+2.1%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to GUG. GUG was compared to 0 industry peers in the Unkown industry. GUG has a bad profitability rating. Also its financial health evaluation is rather negative. GUG has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year GUG has reported negative net income.
GUG Yearly Net Income VS EBIT VS OCF VS FCFGUG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 -200M -400M -600M -800M

1.2 Ratios

Industry RankSector Rank
ROA -1.05%
ROE -1.35%
ROIC 3.11%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GUG Yearly ROA, ROE, ROICGUG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 -5 -10

1.3 Margins

Industry RankSector Rank
OM 58.98%
PM (TTM) N/A
GM 59.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GUG Yearly Profit, Operating, Gross MarginsGUG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 -100 -200 -300 -400

1

2. Health

2.1 Basic Checks

The number of shares outstanding for GUG remains at a similar level compared to 1 year ago.
The debt/assets ratio for GUG has been reduced compared to a year ago.
GUG Yearly Shares OutstandingGUG Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 10M 20M 30M
GUG Yearly Total Debt VS Total AssetsGUG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 200M 400M 600M 800M

2.2 Solvency

GUG has an Altman-Z score of 1.72. This is a bad value and indicates that GUG is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 0.26 indicates that GUG is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 1.72
ROIC/WACCN/A
WACCN/A
GUG Yearly LT Debt VS Equity VS FCFGUG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 500M -500M

2.3 Liquidity

A Current Ratio of 0.02 indicates that GUG may have some problems paying its short term obligations.
GUG has a Quick Ratio of 0.02. This is a bad value and indicates that GUG is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
GUG Yearly Current Assets VS Current LiabilitesGUG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 50M 100M 150M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 89.42% over the past year.
The Revenue has grown by 183.01% in the past year. This is a very strong growth!
EPS 1Y (TTM)89.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%219.3%
Revenue 1Y (TTM)183.01%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%23.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GUG Yearly Revenue VS EstimatesGUG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 10M 20M 30M 40M
GUG Yearly EPS VS EstimatesGUG Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

GUG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GUG Price Earnings VS Forward Price EarningsGUG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GUG Per share dataGUG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

GUG has a Yearly Dividend Yield of 8.38%, which is a nice return.
GUG's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 8.38%

5.2 History

GUG has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
GUG Yearly Dividends per shareGUG Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.5 1

5.3 Sustainability

GUG has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-330.06%
EPS Next 2YN/A
EPS Next 3YN/A
GUG Yearly Income VS Free CF VS DividendGUG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2022 2023 0 -200M -400M -600M -800M

GUGGENHEIM ACTIVE ALLOCATION

NYSE:GUG (3/7/2025, 8:04:00 PM)

15.59

+0.32 (+2.1%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners26.65%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change-0.58%
Market Cap514.16M
AnalystsN/A
Price TargetN/A
Short Float %0.12%
Short Ratio0.36
Dividend
Industry RankSector Rank
Dividend Yield 8.38%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-330.06%
Div Incr Years1
Div Non Decr Years1
Ex-Date02-14 2025-02-14 (0.11875)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.6
P/FCF N/A
P/OCF N/A
P/B 0.97
P/tB 0.97
EV/EBITDA N/A
EPS(TTM)-0.22
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.34
BVpS16
TBVpS16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.05%
ROE -1.35%
ROCE 4.94%
ROIC 3.11%
ROICexc 3.11%
ROICexgc 3.13%
OM 58.98%
PM (TTM) N/A
GM 59.03%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z 1.72
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%219.3%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)183.01%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%23.18%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y180.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y111.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y111.17%
OCF growth 3YN/A
OCF growth 5YN/A